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Regioselective lithiation and electrophilic quench of N-Boc-3-
phenyltetrahydroisoquinoline 
Ruaa A. Talk,[a] Ashraf El-Tunsi,[a] Craig C. Robertson,[a] and Iain Coldham*[a] 
Abstract: Tetrahydroisoquinolines are found in many natural 
products and drug compounds and a convenient method to access 
1-substituted derivatives is to carry out lithiation at C-1 followed by 
trapping with an electrophile. Here we explore the feasibility of 
lithiation at C-3 by using a substrate with a benzylic proton on both 
sides of the nitrogen atom such that lithiation with nBuLi could occur 
at either C-1 or C-3 of the tetrahydroisoquinoline. The 
regioselectivity in the lithiation was determined using the substrate 
N-tert-butoxycarbonyl (Boc)-3-phenyltetrahydroisoquinoline. The 
lithiation could be followed by in situ ReactIR spectroscopy and the 
rate of rotation of the carbamate group was determined (barrier to 
rotation was approximately ΔG
à
 58 kJ/mol at Ð50 ¡C). Subsequent 
trapping of the organolithium with an electrophile gave a mixture of 
two regioisomeric products with a preference for reaction at C-1. 
This led to the isolation of 1,3-disubstituted tetrahydroisoquinolines 
with trans relative stereochemistry. Removal of the Boc group from 
the nitrogen atom gave secondary and tertiary amine products.  
Introduction 
The tetrahydroisoquinoline ring system is an important scaffold 
in natural products and biologically active compounds.
[1]
 Alkyl, 
benzyl or other functional groups at C-1 and/or C-3 of this ring 
system provide the most common substitution pattern. In 
contrast, tetrahydroisoquinolines with an aryl group at C-3 are 
relatively uncommon. Some examples are canadine 
(tetrahydroberberine)
[2]
 and coralydine,
[3]
 which are 
protoberberine alkaloids, and the N-methyl D-aspartate (NMDA) 
receptor antagonist dizocilpine (MK801) (Figure 1).
[4]  
 
Figure 1. Examples of 3-aryltetrahydroisoquinolines. 
 There are many routes for the synthesis of 
tetrahydroisoquinoline derivatives, in particular the PictetÐ
Spengler and BischlerÐNapieralski reactions that involve 
cyclization starting from a 2-arylethylamine.
[5]
 Methods that 
employ the parent isoquinoline or 3,4-dihydroisoquinoline ring 
systems have been developed by using reduction or nucleophilic 
addition.
[6]
 Alternatively, metallated tetrahydroisoquinolines can 
act as nucleophiles to react with electrophiles.
[7]
 We found that 
the N-tert-butoxycarbonyl (Boc) group, popularised by Beak and 
co-workers,
[8]
 is effective at allowing lithiation at C-1 with nBuLi 
in THF,
[9]
 particularly if the reaction is conducted at Ð50 ¡C rather 
than Ð78 ¡C, as this allows faster rotation of the Boc group to 
which the nBuLi is coordinated.
[10,11]
 
 In our earlier work, we found that lithiation occurs at the 
benzylic position (C-1) on treatment of N-Boc- 
tetrahydroisoquinoline with nBuLi.
[9]
 We were interested to 
determine the regioselectivity when an aryl group was located at 
C-3. The substrate selected was N-Boc-3-
phenyltetrahydroisoquinoline 1 (rotamers 1a and 1b, Scheme 1) 
and this has a benzylic CÐH on both sides of the N-Boc group 
(at C-1 and C-3). Therefore it is feasible that lithiation could 
occur at either C-1 or C-3. If rotation of the Boc group in 
compound 1 is fast then coordination of BuLi would allow 
lithiation at either C-1 or C-3 and the ratio of regioisomers of the 
lithiatedÐtrapped product would reflect the preference for 
lithiation at one of these positions. However, if rotation of the 
Boc group is slow relative to lithiation, then the ratio of the 
regioisomeric products after trapping with an electrophile should 
reflect the ratio of the rotamers 1a and 1b (since lithiation occurs 
only after coordination of BuLi to the carbonyl oxygen atom).
[10,11]
 
We describe here the regioselectivity in this lithiationÐtrapping 
chemistry.  
 
Scheme 1. Rotamers of N-Boc-3-phenyltetrahydroisoquinoline 1. 
Results and Discussion 
The target compound N-Boc-3-phenyltetrahydroisoquinoline 1 
was prepared by reduction then Boc protection of the known 3-
phenyl-3,4-dihydroisoquinoline 2 (Scheme 2).
[12]
 The 
1
H NMR 
spectrum of N-Boc-3-phenyltetrahydroisoquinoline 1 in D8-THF 
showed a mixture of rotamers at low temperature with a ratio 
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1.2:1. Coalescence of the two tert-butyl singlets occurred at just 
below room temperature and a broad peak for the tert-butyl 
group was observed at room temperature (Figure 2). Line shape 
analysis of these data (see SI) led to rate constants from which 
an Eyring plot revealed approximate activation parameters of 
ΔH
à
 61 kJ/mol and ΔS
à
 16 J/K/mol (assuming 1:1 ratio of 
rotamers). Hence the barrier to rotation can be estimated as ΔG
à
 
~58 kJ/mol at Ð50 ¡C, with a half-life for rotation (1a ! 1b) of 
only about 5 sec at Ð50 ¡C. 
 
Scheme 2. Preparation of tetrahydroisoquinoline 1. 
 
Figure 2. Variable temperature 
1
H NMR spectra of 1 in D8-THF (showing 
region 1.85Ð1.10 ppm, peak at 1.76 ppm for THF). 
 Lithiation of N-Boc-3-phenyltetrahydroisoquinoline 1 using 
nBuLi in THF occurred rapidly at Ð50 ¡C. This was verified by in 
situ IR (ReactIR) spectroscopy (Figure 3).
[13]
 Two peaks could 
be observed for the carbonyl stretch of the lithiated intermediate 
(at 1642 and 1632 cm
Ð1
), probably relating to lithiation at C-1 
and at C-3. 
 On the basis of the VT-NMR and IR spectroscopic studies, 
the lithiation of N-Boc-3-phenyltetrahydroisoquinoline 1 was 
carried out by using nBuLi in THF at Ð50 ¡C for 4 min, followed 
by addition of a variety of electrophiles (Scheme 3). Good yields 
of a range of different substituted products were obtained and in 
all cases a mixture of the 1- and 3-substituted products (4 and 5) 
were formed. 
 
 
Figure 3. ReactIR spectra for lithiation of tetrahydroisoquinoline 1 with nBuLi 
added at 12 min in THF at Ð50 ¡C; νC=O at 1694 cm
Ð1
 for 1 and νC=O at 1642 
(and 1632) cm
Ð1
 for lithiated 1 (Time in h:min:sec). 
 
Scheme 3. LithiationÐsubstitution of tetrahydroisoquinoline 1. 
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 The ratio of these products was typically around 3:1 in 
favour of reaction at C-1, suggesting that rotation of the Boc 
group (ratio of rotamers 1.2:1) is faster than lithiation. The 
preference for lithiation at C-1 may be due to steric reasons or 
possibly due to a slightly greater acidity at this position. In all 
cases, the C-1 substituted products 4 were obtained as a single 
stereoisomer. For product 4a this was determined to be the 
trans isomer by single crystal X-ray analysis (Figure 4).
[14]
  
 
Figure 4. Crystal structure for 4a with thermal ellipsoids at 50% calculated 
displacement parameter. 
 To further investigate the regioselectivity in the lithiationÐ
trapping of N-Boc-3-phenyltetrahydroisoquinoline 1 and to avoid 
any steric effects of the electrophile, we trapped the 
organolithium intermediates with D2O. This gave the same two 
regioisomeric products (4g and 5g, 93% yield, Scheme 4). The 
ratio of the regioisomers was 2:1 (C-1 to C-3) which was similar 
to that for the products on using alkyl halide electrophiles. The 
reactivity of the electrophile does have some effect on the 
selectivity, as can be seen from the small differences in the ratio 
of the regioisomers (Scheme 3). It is possible that the best ratios 
(4:1), obtained for iodomethane and bromobutane as the 
electrophiles (to give predominantly 4a and 4b respectively), 
could be due to the poorer reactivity of these electrophiles
[11c]
 
and slower reaction at the more hindered C-3 position. The α-
amino-organolithiums at C-1 and at C-3 could potentially be 
interconverting and these are likely to react at different rates with 
the different electrophiles. An attempt to verify this was made by 
reacting the stannane 4f with nBuLi (THF, Ð50 ¡C) followed by 
addition of MeI. Although tinÐlithium exchange occurred, no 
methylated product was isolated. The same experiment with the 
3-stannyl compound 5f at Ð50 ¡C gave only the recovered 
stannane. However, on warming this mixture to room 
temperature tinÐlithium exchange took place and addition of MeI 
gave the 3-methylated product 5a as the only observable isomer 
(90% yield). These results are inconclusive but suggest that 
there is no conversion of the 3-lithiated intermediate to the 1-
lithiated intermediate under the reaction conditions. 
 At the lower temperature of Ð78 ¡C, the rate of rotation of 
the Boc group is reduced and the half-life for rotation can be 
calculated to be approximately 11 min. Lithiation is more rapid 
than rotation at this temperature, so the ratio of the 
organolithium intermediates should match the ratio of rotamers 
(1.2:1). Indeed, on quenching the mixture of organolithiums 
formed at Ð78 ¡C with D2O, the deuterated products 4g and 5g 
were formed in high yield as a 1.2:1 mixture (Scheme 4). 
Carrying out the lithiationÐtrapping at 0 ¡C gave the same ratio 
of products as that found at Ð50 ¡C, indicating that at Ð50 ¡C or 
at higher temperatures the Boc group is rotating faster than 
lithiation. 
 
Scheme 4. LithiationÐdeuteration of tetrahydroisoquinoline 1. 
 It is possible that the size of the base could affect the ratio 
of regioisomers. However, on using sBuLi in THF at Ð50 ¡C, the 
products 4d and 5d had very similar levels of selectivity (62%, 
3:1). Likewise, on using Schlosser's base (nBuLi + KOtBu) these 
products were formed in 66% yield with a ratio of 4:1 in favour of 
4d. We also explored incorporating the additive TMEDA in the 
solvents THF, Et2O, or cyclopentyl methyl ether but these too 
gave almost identical results (to using nBuLi in THF), with the 
products 4a and 5a being formed in high yields (89Ð93%) and 
with the same regioselectivity (ratio 4:1 in favour of 4a).  
 As mentioned above, the product 4a could be isolated by 
recrystallisation, although we generally did not separate the 
mixture of regioisomers. The mixtures of 4bÐe and 5bÐe were 
treated with trifluoroacetic acid (TFA) to remove the Boc group. 
With the mixture of 4d and 5d we were able to isolate the 
amines 6d and 7d (Scheme 5). In the other cases, it was only 
possible to isolate the amines 6b, 6c and 6e. The product 6e 
was recrystallised and the stereochemistry was confirmed as 
trans by single crystal X-ray analysis (see SI),
[13]
 which matched 
that obtained for product 4a (Figure 4). Other products are 
assumed to have the same trans stereochemistry. 
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Scheme 5. Removal of the Boc group from the carbamate 4 and 5. 
 As further examples, we prepared the tricyclic products 8Ð
11 by lithiation of tetrahydroisoquinoline 1 followed by trapping 
with 1,3-dibromopropane or 1,4-dibromobutane and then 
treatment with TFA (Scheme 6). In both cases the regioisomeric 
products could be separated by column chromatography. These 
products have potential biological activity for example as anti-
depressants and compound 8 has been screened as an 
antagonist of tetrabenazine-induced ptosis and as an inhibitor of 
dopamine, norepinephrine, and serotonin uptake.
[15,16]
  
 
Scheme 6. Preparation of the tricyclic amines 8 and 9. 
Conclusions 
The regioselectivity in the lithiation and trapping of N-Boc-3-
phenyltetrahydroisoquinoline was investigated and found to give 
a mixture of products that favour reaction at C-1. The barrier to 
rotation of the carbamate was determined and the half-life was 
found to be several minutes at Ð78 ¡C but only a few seconds at 
Ð50 ¡C. This has implications for the selectivity as at the lower 
temperature the ratio of regioisomeric products matched the 
ratio of carbamate rotamers (about 1.2:1). This indicated that the 
lithiation occurs more quickly than the rotation at Ð78 ¡C. 
However at Ð50 ¡C and above, lithiation was slower than rotation 
and this allowed higher selectivities in the reaction (ratio of 
regioisomers up to 4:1). This selectivity is likely a result of the 
less hindered environment at C-1 although bases with different 
steric bulk gave similar results. The products from substitution at 
C-1 were found to have trans stereochemistry. It was possible to 
remove the Boc group using acid to give a selection of bicyclic 
and tricyclic amine products. 
Experimental Section 
tert-Butyl 3-Phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate 1: Di-
tert-butyl dicarbonate (0.4 g, 1.9 mmol) was added to 3-
phenyltetrahydroisoquinoline 3 (3.0 g, 19 mmol) in waterÐdioxane (3 mL, 
1:2) at 0 ¡C. After 4 h, the mixture was allowed to warm to room 
temperature. After 16 h, the mixture was extracted with Et2O (3 × 20 mL) 
then the extracts were washed with saturated brine solution (20 mL), 
dried (MgSO4) and the solvent was evaporated. Purification by flash 
column chromatography on silica, eluting with petrolÐEtOAc (97:3), gave 
the carbamate 1 (0.5 g, 79%) as an amorphous solid; m.p 70Ð73 ¡C; RÄ 
0.23  [petrolÐEtOAc (90:10)]; FTIR νmax (film)/cm
Ð1 
3005, 2975, 1690, 
1455; 
1
H NMR (400 MHz, CDCl3, rotamers) δ = 7.25Ð7.14 (9H, m, ArH), 
5.38 (1H, br s, CH), 4.85 (1H, d, J 16 Hz, CH), 4.31Ð4.27 (1H, m, CH), 
3.36Ð3.31 (1H, m, CH), 3.14Ð3.10 (1H, m, CH), 1.40 (9H, br s, t-Bu); 
13
C 
NMR (100 MHz, CDCl3, rotamers, some aromatic signals could not be 
observed) δ = 155.2, 142.4, 133.8, 128.2, 126.9, 126.8, 126.4, 126.0, 
80.0, 54.4, 43.8, 35.9, 28.4; HRMS (ES) Found: MNa
+
, 332.1614. 
C20H23NO2Na requires MNa
+
 332.1626; LRMS m/z (ES) 332 (100%, 
MNa
+
). 
3-Phenyl-1,2,3,4-tetrahydroisoquinoline 3: NaBH4 (3.6 g, 96 mmol) 
was added in portions to a solution of the imine 2 (9.9 g, 47.8 mmol, 
prepared according to the literature
[12]
) in methanol (100 mL) at 0 ¡C. 
After 3 h, aqueous NaOH (20 mL, 2 M) was added and the solvent was 
evaporated. The residue was extracted using CH2Cl2 (2 × 150 mL), dried 
(MgSO4), evaporated and the residue was purified by column 
chromatography on silica, eluting with CH2Cl2ÐMeOH (92:8), to give the 
amine 3 (6.1 g, 61%) as an oil; Rf  0.21 [CH2Cl2ÐMeOH (90:10)]; 
1
H NMR 
(400 MHz, CDCl3,) δ = 7.47Ð7.45 (1H, m, ArH), 7.41Ð7.37 (2H, m, 2 × 
ArH), 7.33Ð7.30 (2H, m, 2 × ArH), 7.20Ð7.10 (4H, m, 4 × ArH), 4.31 (1H, 
d, J 16 Hz, CH), 4.21 (1H, d, J 16 Hz, CH), 4.07Ð4.03 (1H, m, CH), 3.02Ð
3.00 (2H, m, 2 × CH), 1.90 (1H, br s, NH). Data in accordance with the 
literature.
[17] 
tert-Butyl (1R,3S)-1-Methyl-3-phenyl-3,4-dihydro-1H-isoquinoline-2-
carboxylate 4a and  tert-Butyl 3-Methyl-3-phenyl-1,4-
dihydroisoquinoline-2-carboxylate 5a:  
nBuLi (0.2 mL, 0.5 mmol, 2.5 M in hexane) was added to the carbamate 
1 (100 mg, 0.32 mmol) in dry THF (2 mL) at Ð50 ¼C under nitrogen. After 
4 minutes, iodomethane (0.07 mL, 1.2 mmol) was added. The mixture 
was allowed to warm slowly to room temperature and MeOH (1 mL) was 
added. The solvent was evaporated and the residue was purified by flash 
column chromatography on silica, eluting with petrolÐEtOAc (95:5), to 
give the carbamates 4a and 5a (92 mg, 88%), ratio 4:1. 
Carbamate 4a could be recrystallised from hexaneÐCH2Cl2 to give cubes 
(75 mg); Rf 0.41 [petrolÐEtOAc (90:10)]; FTIR νmax (film)/cm
Ð 1
 3000, 2920, 
1690, 1455; 
1
H NMR (400 MHz, CDCl3, rotamers) δ = 7.21Ð7.20 (2H, m, 
2 × ArH), 7.11Ð7.06 (4H, m, 4 × ArH), 6.89Ð6.83 (3H, m, 3 × ArH), 5.50Ð
5.19 (2H, m, 2 × CH), 3.59Ð3.55 (1H, m, CH), 2.87Ð2.83 (1H, m, CH), 
1.52 (3H, d, J 7 Hz, CH3), 1.19 (9H, br s, t-Bu); 
13
C NMR (100 MHz, 
CDCl3, rotamers) δ = 155.0, 145.1, 140.0, 131.7, 128.5, 127.6, 127.0, 
126.9, 126.1, 125.9, 125.5, 79.6, 56.6, 52.4, 36.0, 28.5 & 28.1, 14.1; 
HRMS (ES) Found: MNa
+
, 346.1790. C21H25NO2Na requires MNa
+
 
346.1783; LRMS m/z (ES) 346 (100%, MNa
+
); CCDC 1889261.
 
Carbamate 5a was an oil (17 mg); Rf 0.41 [petrolÐEtOAc (80:20)]; FTIR 
νmax (film)/cm
Ð 1
 3000, 2920, 1690, 1455; 
1
H NMR (400 MHz, CDCl3, 
rotamers) δ = 7.32Ð7.27 (8H, m, 8 × ArH), 7.09Ð7.08 (1H, m, 1 × ArH), 
4.91 (1H, d, J 15 Hz, CH), 4.67 (1H, d, J 15 Hz, CH), 3.06 (1H, d, J 14.5 
Hz, CH), 2.83 (1H, d, J 14.5 Hz, CH), 1.67 (3H, s, CH3), 1.09 (9H, br s, t-
Bu); 
13
C NMR (100 MHz, CDCl3, rotamers, C=O could not be observed) δ 
= 149.6, 136.0, 135.8, 127.9, 127.4, 127.1, 126.7, 126.0, 125.8, 124.5, 
79.8, 60.3, 48.0, 46.3, 28.0, 25.2; HRMS (ES) Found: MNa
+
, 346.1789. 
C21H25NO2Na, requires MNa
+
; 346.1780, LRMS m/z (ES) 346 (100%, 
MNa
+
). 
Alternatively, carbamate 5a was formed from the stannane 5f (67 mg, 
0.13 mmol) in THF (2 mL) by addition of nBuLi (0.05 mL, 0.13 mmol, 2.5 
M in hexane) at room temperature. After 5 min, iodomethane (0.02 mL, 
0.34 mmol) was added. MeOH (1 mL) was added and the solvent was 
evaporated. The residue was purified by flash column chromatography 
on silica, eluting with petrolÐEtOAc (95:5), gave the carbamate 5a (32 mg, 
90%) as an oil; data as above.  
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tert-Butyl 1-Butyl-3-phenyl-3,4-dihydro-1H-isoquinoline-2-
carboxylate 4b and  tert-Butyl 3-Butyl-3-phenyl-1,4-
dihydroisoquinoline-2-carboxylate 5b:  
nBuLi (0.24 mL, 0.6 mmol, 2.5 M in hexane) was added to the carbamate 
1 (120 mg, 0.4 mmol) in dry THF (2 mL) at Ð50 ¼C under nitrogen. After 4 
minutes, 1-bromobutane (0.13 mL, 1.2 mmol) was added. The mixture 
was allowed to warm slowly to room temperature and MeOH (1 mL) was 
added. The solvent was evaporated and the residue was purified by flash 
column chromatography on silica, eluting with petrolÐEtOAc (95:5), to 
give the carbamates 4b and 5b (140 mg, 97%), ratio 4:1 as an 
inseparable mixture, as an oil; RÄ 0.57 [petrolÐEtOAc (80:20)]; FTIR νmax 
(film)/cm
Ð1
 3005, 2955, 2925, 1685, 1170; 
1
H NMR (400 MHz, CDCl3, 
rotamers) δ = 7.21Ð7.07 (6H, m, 6 × ArH), 6.89Ð6.80 (3H, m, 3 × ArH), 
5.48Ð5.19 (1.6H, m, CH), 4.99Ð4.96 (0.2H, m, CH), 4.34 (0.2H, d, J 14.5 
Hz, CH), 3.65!3.57 (0.8H, m, CH), 3.35 (0.2H, d, J 14.5 Hz, CH), 2.89Ð
2.52 (1H, m, CH), 2.19Ð2.03 (1H, m, CH), 1.68Ð1.60 (1H, m, CH), 1.47Ð
1.11 (16H, m, 7 × CH, t-Bu); 
13
C NMR (100 MHz, CDCl3, rotamers) δ = 
155.1, 145.3, 138.3, 136.0, 135.6, 133.8 & 133.5, 132.2, 128.7 &  128.6, 
128.2 & 128.1, 128.0 & 127.9, 127.6, 127.4, 127.3, 127.1 & 127.0, 126.5 
& 126.4, 126.2, 126.1, 125.6, 125.5 & 125.4, 124.7, 124.5, 76.6 & 76.5, 
62.3, 57.9 & 57.0, 56.6 & 55.9, 46.9, 44.4, 43.7 & 43.1, 40.6 & 39.9, 37.0, 
36.2, 29.3 & 28.9, 28.5 & 28.3, 28.0, 27.3 & 26.6, 23.2 & 22.7, 14.2, 14.1; 
HRMS (ES) Found: MNa
+
, 388.2240. C24H31NO2Na requires MNa
+
 
388.2247; LRMS m/z (ES) 388 (100%, MNa
+
). 
tert-Butyl 3-Phenyl-1-(prop-2-en-1-yl)-3,4-dihydro-1H-isoquinoline-2-
carboxylate 4c and tert-Butyl 3-Phenyl-3-(prop-2-en-1-yl)-1,4-
dihydroisoquinoline-2-carboxylate 5c: 
nBuLi (1.0 mL, 2.4 mmol, 2.4 M in hexane) was added to the carbamate 
1 (500 mg, 1.6 mmol) in dry THF (8 mL) at Ð50 ¼C under nitrogen. After 4 
minutes, allyl bromide (0.42 mL, 2.9 mmol) was added. The mixture was 
allowed to warm slowly to room temperature and MeOH (1 mL) was 
added. The solvent was evaporated and the residue was purified by flash 
column chromatography on silica, eluting with petrolÐEtOAc (90:10), to 
give the carbamates 4c and 5c (460 mg, 82%), ratio 2.3:1 as an 
inseparable mixture, as an oil; RÄ 0.58 [petrolÐEtOAc (80:20)]; FTIR νmax 
(film)/cm
Ð1
 2970, 2945, 2930, 1690, 1495, 1170; 
1
H NMR (400 MHz, 
CDCl3, rotamers) δ = 7.24Ð7.07 (6H, m, 6 × ArH), 6.89Ð6.80 (3H, m, 3 × 
ArH), 5.94Ð5.88 (0.3H, m, CH), 5.81Ð5.72 (0.7H, m, CH), 5.53Ð5.15 (2H, 
m, 2 × CH), 5.04Ð4.97 (1.7H, m, CH), 4.27 (0.3H, d, J 14.5 Hz, CH), 
3.61Ð3.53 (1H, m, CH), 3.41 (0.3H, d, J 14.5 Hz, CH), 2.92Ð2.76 (1.7H, 
m, CH), 2.68 (0.3H, d, J 14.5 Hz, CH), 2.50Ð2.43 (0.7H, m, CH), 1.18Ð
1.13 (9H, m, t-Bu); 
13
C NMR (100 MHz, CDCl3, rotamers) δ = 155.1, 
145.2, 134.8, 128.5, 127.7, 127.6, 127.5, 127.3, 127.2, 126.3, 126.2, 
125.8, 125.5, 125.4, 124.4, 119.0, 117.6, 79.9, 79.7, 61.9, 60.4, 58.0, 
57.0, 56.8, 56.6, 56.0, 46.8, 44.1, 43.8, 41.8, 36.4, 36.2, 28.6, 28.1, 27.6; 
HRMS (ES) Found: MNa
+
, 372.1942. C23H27NO2Na requires MNa
+
 
372.1943; LRMS m/z (ES) 372 (100%). 
tert-Butyl 1-Benzyl-3-phenyl-3,4-dihydro-1H-isoquinoline-2-
carboxylate 4d and tert-Butyl 3-Benzyl-3-phenyl-1,4-
dihydroisoquinoline-2-carboxylate 5d: 
nBuLi (0.3 mL, 0.7 mmol, 2.4 M in hexane) was added to the carbamate 
1 (150 mg, 0.48 mmol) in dry THF (3 mL) at Ð50 ¼C under nitrogen. After 
4 minutes, benzyl bromide (0.4 mL, 1.4 mmol) was added. The mixture 
was allowed to warm slowly to room temperature and MeOH (1 mL) was 
added. The solvent was evaporated and the residue was purified by flash 
column chromatography on silica, eluting with petrolÐEtOAc (90:10), to 
give the carbamates 4d and 5d (150 mg, 82%), ratio 3:1 as an 
inseparable mixture, as an oil; RÄ 0.28 [petrolÐEtOAc (90:10)]; FTIR νmax 
(film)/cm
Ð1
 2970, 2930, 2920, 1685, 1495, 1170; 
1
H NMR (400 MHz, 
CDCl3, rotamers) δ = 7.36Ð7.03 (9H, m, 9 × ArH), 6.96Ð6.67 (5H, m, 5 × 
ArH), 5.47Ð5.42 (0.75H, m, CH), 5.29Ð5.23 (0.75H, m, CH), 5.05 (0.25H, 
d, J 15 Hz, CH), 4.18 (0.25H, d, J 15 Hz, CH), 3.48 (0.25H, d, J 15 Hz, 
CH), 3.39Ð3.30 (1H, m, CH), 3.20Ð2.96 (1.75H, m, CH), 2.79 (0.25H, d, J 
15 Hz, CH), 2.70Ð2.62 (0.75H, m, CH), 1.29Ð1.18 (9H, m, t-Bu); 
13
C 
NMR (100 MHz, CDCl3, rotamers) δ = 155.1 & 154.6, 145.2, 144.0, 138.1 
& 137.9, 137.7, 136.7, 136.4 & 136.2, 135.2 & 135.0, 132.6 & 132.2, 
131.2, 130.1, 129.9, 128.3 & 128.2, 128.0, 127.9, 127.6 & 127.5, 127.4, 
127.3, 127.1, 127.0 & 126.9, 126.7 & 126.6, 126.4, 126.2 & 126.1, 126.0, 
125.8 & 125.7, 125.5, 125.3, 125.1, 124.4, 80.3 & 80.1, 79.7, 62.7, 59.6 
& 58.7, 56.6 & 56.1, 46.3 & 44.3, 43.7 & 43.4, 42.8 & 42.7, 36.1 & 36.0, 
29.7, 28.7 & 28.4, 28.2 & 28.1; HRMS (ES) Found: MH
+
, 422.2083. 
C27H29NO2Na requires MNH
+
 422.2096; LRMS m/z (ES) 422 (100%, 
MNa
+
). 
tert-Butyl 1-[(4-Methylphenyl)methyl]-3-phenyl-3,4-dihydro-1H-
isoquinoline-2-carboxylate 4e and tert-Butyl 3-[(4-
Methylphenyl)methyl]-3-phenyl-1,4-dihydroisoquinoline-2-
carboxylate 5e: 
nBuLi (0.6 mL, 1.4 mmol, 2.4 M in hexane) was added to the carbamate 
1 (300 mg, 0.96 mmol) in dry THF (6 mL) at Ð50 ¼C under nitrogen. After 
4 minutes, 4-methylbenzyl bromide (500 mg, 2.9 mmol) was added. The 
mixture was allowed to warm slowly to room temperature and MeOH (1 
mL) was added. The solvent was evaporated and the residue was 
purified by flash column chromatography on silica, eluting with petrolÐ
EtOAc (95:5), to give the carbamates 4e and 5e (370 mg, 94%), ratio 3:1 
as an inseparable mixture, as an oil; RÄ 0.3 [petrolÐEtOAc (90:10)]; FTIR 
νmax (film)/cm
Ð1
 3025, 2970, 2925, 1690, 1120; 
1
H NMR (400 MHz, CDCl3, 
rotamers) δ = 7.26Ð7.02 (8H, m, 8 × ArH), 6.93Ð6.69 (5H, m, 5 × ArH), 
5.49Ð5.42 (0.75H, m, CH), 5.29Ð5.22 (0.75H, m, CH), 5.07 (0.25H, d, J 
15 Hz, CH), 4.15 (0.25H, d, J 15 Hz, CH), 3.49 (0.25H, d, J 15 Hz, CH), 
3.62Ð2.94 (2.75H, m, CH), 2.79 (0.25H, d, J 15 Hz, CH), 2.71!2.60 
(0.75H, m, CH), 2.37 (0.75H, s, CH3), 2.34 (2.25H, s, CH3), 1.30Ð1.19 
(9H, m, t-Bu); 
13
C NMR (100 MHz, CDCl3, rotamers) δ = 155.1 & 154.6, 
145.3, 144.1, 136.9 & 136.6, 136.3, 136.2, 135.7 & 135.6, 135.4, 135.0 & 
134.8, 134.5, 132.6 & 132.3, 131.1, 129.9 & 129.7, 129.0, 128.7 & 128.6, 
128.4, 128.2, 127.8, 127.7, 127.6, 127.3 & 127.2, 127.1 & 127.0, 126.3, 
126.1, 126.0, 125.8, 125.5 & 125.3, 125.1, 124.4, 80.3 & 80.0, 79.7, 62.7, 
59.6 & 58.7, 56.6 & 56.1, 46.3 & 43.9, 43.0, 42.7 & 42.4, 36.2 & 36.0, 
29.7, 28.7 & 28.4, 28.2 & 28.1, 21.2, 21.1; HRMS (ES) Found: MNa
+
, 
436.2227. C28H31NO2Na requires MNa
+
 436.2247; LRMS m/z (ES) 436 
(100%, MNa
+
). 
tert-Butyl 3-Phenyl-1-(tributylstannyl)-3,4-dihydro-1H-isoquinoline-2-
carboxylate 4f and tert-Butyl 3-Phenyl-3-(tributylstannyl)-1,4-
dihydroisoquinoline-2-carboxylate 5f: 
nBuLi (0.47 mL, 1.2 mmol, 2.5 M in hexane) was added to the carbamate 
1 (300 mg, 1.0 mmol) in dry THF (6 mL) at Ð50 ¼C under argon. After 4 
minutes, Bu3SnCl (0.8 mL, 2.9 mmol) was added. The mixture was 
allowed to warm slowly to room temperature and MeOH (3 mL) was 
added. The solvent was evaporated and the residue was purified by flash 
column chromatography on silica, eluting with petrolÐEtOAc (99:1), to 
give the carbamates 4f and 5f (460 mg, 79%), ratio 1:1. 
Carbamate 4f was an oil (233 mg); RÄ 0.5 [petrolÐEtOAc (95:5)]; FTIR 
νmax (film)/cm
Ð1
 3005, 2975, 1685, 1515, 1150; 
1
H NMR (400 MHz, CDCl3, 
rotamers) δ = 7.14Ð6.80 (9H, m, 9 × ArH), 5.46Ð5.23 (2H, m, CH), 3.16Ð
2.98 (2H, m, CH), 1.77Ð1.49 (9H, br, t-Bu), 1.40Ð1.33 (12H, m, 3 × 
CH2CH2), 1.14Ð0.85 (15H, m, 3 × CH2 and 3 × CH3); 
13
C NMR (100 MHz, 
CDCl3) δ = 153.9, 144.6, 140.6, 129.9, 128.2, 127.8, 126.8, 126.3, 125.9, 
124.2, 123.3, 79.5, 55.7, 50.1, 37.2, 29.0, 28.4, 27.6, 13.8, 11.0; HRMS 
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(ES) Found: MNa
+
, 622.2706. C32H49NO2
120
SnNa requires MNa
+
 
622.2683; LRMS m/z (ES) 622 (100%, MNa
+
). 
Carbamate 5f was an oil (227 mg); RÄ 0.67 [petrolÐEtOAc (95:5)]; FTIR 
νmax (film)/cm
Ð1
 3005, 2975, 1685, 1515, 1150; 
1
H NMR (400 MHz, CDCl3, 
rotamers) δ = 7.23Ð6.89 (9H, m, 9 × ArH), 4.83 (1H, d, J 16 Hz, CH), 
4.19 (1H, d, J 16 Hz, CH), 3.61 (1H, d, J 16 Hz, CH), 3.43 (1H, d, J 16 Hz, 
CH), 1.59 (9H, s, t-Bu), 1.41Ð1.25 (12H, m, 3 × CH2CH2), 0.89Ð0.73 (15H, 
m, 3 × CH2 and 3 × CH3); 
13
C NMR (100 MHz, CDCl3, one aromatic CH 
overlapping) δ = 157.2, 144.8, 134.8, 133.4, 128.7, 128.1, 126.1, 125.8, 
124.8, 124.0, 80.4, 56.0, 43.8, 36.3, 29.1, 28.5, 27.7, 13.8, 13.3; HRMS 
(ES) Found: MNa
+
, 622.2706. C32H49NO2
120
SnNa requires MNa
+
 
622.2683; LRMS m/z (ES) 622 (100%, MNa
+
). 
tert-Butyl 3-Phenyl-3,4-dihydro(1-!H!)-1H-isoquinoline-2-carboxylate 
4g  tert-Butyl 3-Phenyl-1,4-dihydro(3-!H)isoquinoline-2-carboxylate 
5g: 
nBuLi (0.2 mL, 0.5 mmol, 2.4 M in hexane) was added to the carbamate 
1 (100 mg, 0.32 mmol) in dry THF (2 mL) at Ð50 ¼C under nitrogen. After 
4 minutes, D2O (0.02 mL, 1.0 mmol) was added. The mixture was 
allowed to warm slowly to room temperature and the solvent was 
evaporated. The residue was purified by flash column chromatography 
on silica, eluting with petrolÐEtOAc (99:1), to give the carbamates 4g and 
5g (93 mg, 93%), ratio 2:1 as an inseparable mixture, as an oil; RÄ  0.23 
[petrolÐEtOAc (90:10)]; FTIR νmax (film)/cm
Ð1 
3005, 2975, 2925, 1690, 
1160; 
1
H NMR (400 MHz, CDCl3, rotamers) δ = 7.20Ð7.04 (9H, m, ArH), 
5.25 (0.65H, br s, CH), 4.77 (0.35H, d, J 16 Hz, CH), 4.17Ð4.15 (1H, m, 
CH), 3.22Ð3.20 (1H, m, CH), 3.02Ð2.98 (1H, m, CH), 1.30 (9H, br s, t-Bu); 
13
C NMR (100 MHz, CDCl3, rotamers, one aromatic signal could not be 
observed) δ = 155.3, 142.8, 134.4, 133.8, 128.2, 126.9, 126.8, 126.4, 
126.0, 80.0, 54.4, 43.4 (t, J 22 Hz), 35.0, 28.4; HRMS (ES) Found: MNa
+
, 
333.1682. C20H22DNO2Na requires MNa
+
 333.1684; LRMS m/z (ES) 333 
(100%, MNa
+
); Found: C, 76.91; H, 7.57; N, 4.07. C20H22DNO2 requires C, 
77.39; H, 7.79; N, 4.51. 
1-Butyl-3-phenyl-1,2,3,4-tetrahydroisoquinoline 6b: 
Trifluoroacetic acid (0.06 mL, 0.5 mmol) was added to a mixture (ratio 
4:1) of the carbamates 4b and 5b (100 mg, 0.27 mmol) in CH2Cl2 (5 mL) 
at room temperature. After 4 h, the solvent was evaporated and aqueous 
NaOH (10 mL, 1 M) was added. After 1 h, the mixture was extracted with 
CH2Cl2 (2 × 30 mL). The combined organic extracts were dried (MgSO4) 
and the solvent was evaporated. Purification by flash column 
chromatography on silica, eluting with petrolÐEtOAc (95:5), gave the 
amine 6b (51 mg, 71%) as an oil; Rf 0.45 [petrolÐEtOAc (80:20)]; FT-IR 
νmax (film)/cm
-1
 3315, 2955, 2920, 1490, 1450; 
1
H NMR (400 MHz, CDCl3) 
δ = 7.51Ð7.48 (2H, m, 2 × ArH), 7.42Ð7.38 (2H, m, 2 × ArH), 7.34Ð7.30 
(1H, m, ArH), 7.20Ð7.11 (4H, m, 4 × ArH), 4.28Ð4.24 (1H, m, CH), 4.15Ð
4.12 (1H, m, CH), 3.01Ð2.99 (2H, m, 2 × CH), 2.15 (1H, br s, NH), 1.99Ð
1.93 (1H, m, CH), 1.77Ð1.71 (1H, m, CH), 1.52Ð1.28 (7H, m, 4 × CH and 
CH3); 
13
C NMR (100 MHz, CDCl3) δ = 144.5, 139.3, 134.5, 129.0, 128.6, 
127.4, 127.0, 126.8, 126.1, 125.8, 56.4, 51.6, 37.7, 36.4, 29.2, 22.6, 14.1; 
HRMS (ES) Found: MH
+
, 266.1902. C19H24N, requires MH
+
; 266.1909, 
LRMS m/z (ES) 266 (100%, MH
+
). 
3-Phenyl-1-(prop-2-en-1-yl)-1,2,3,4-tetrahydroisoquinoline 6c: 
Trifluoroacetic acid (0.2 mL, 2.6 mmol) was added to a mixture (ratio 
2.3:1) of the carbamates 4c and 5c (460 mg, 1.3 mmol) in CH2Cl2 (12 
mL) at room temperature. After 4 h, the solvent was evaporated and 
aqueous NaOH (10 mL, 1 M) was added. After 1 h, the mixture was 
extracted with CH2Cl2 (2 × 50 mL). The combined organic extracts were 
dried (MgSO4) and the solvent was evaporated. Purification by flash 
column chromatography on silica, eluting with petrolÐEtOAc (65:35), 
gave the amine 6c (170 mg, 60%) as an oil; Rf 0.37 [petrolÐEtOAc 
(80:20)]; FT-IR νmax (film)/cm
-1
 3350, 2955, 2920, 1630, 1490; 
1
H NMR 
(400 MHz, CDCl3) δ = 7.48Ð7.46 (2H, m, 2 × ArH), 7.41Ð7.37 (2H, m, 2 × 
ArH), 7.34Ð7.30 (1H, m, ArH), 7.20Ð7.12 (4H, m, 4 × ArH), 5.92 (1H, 
dddd, J 15, 9, 6, 3 Hz, CH), 5.21Ð5.16 (2H, m, 2 × CH), 4.33Ð4.14 (2H, m, 
2 × CH), 3.09Ð2.96 (2H, m, 2 × CH), 2.77Ð2.68 (1H, m, CH), 2.62Ð2.56 
(1H, m, CH), 2.22 (1H, br s, NH); 
13
C NMR (100 MHz, CDCl3) δ = 144.3, 
138.0, 135.9, 134.8, 129.0, 128.6, 127.4, 127.0, 126.9, 126.3, 125.8, 
118.4, 55.7, 51.6, 41.3, 37.8; HRMS (ES) Found: MH
+
, 250.1593. 
C18H19N requires MNH
+
 250.1590; LRMS m/z (ES) 250 (100%, MNa
+
). 
1-Benzyl-3-phenyl-1,2,3,4-tetrahydroisoquinoline 6d and 3-Benzyl-3-
phenyl-2,4-dihydro-1H-isoquinoline 7d: 
Trifluoroacetic acid (0.05 mL, 0.6 mmol) was added to a mixture (ratio 
3:1) of the carbamates 4d and 5d (120 mg, 0.3 mmol) in CH2Cl2 (5 mL) 
at room temperature. After 4 h, the solvent was evaporated and aqueous 
NaOH (5 mL, 1 M) was added. After 1 h, the mixture was extracted with 
CH2Cl2 (2 × 20 mL). The combined organic extracts were dried (MgSO4) 
and the solvent was evaporated. Purification by flash column 
chromatography on silica, eluting with petrolÐEtOAc (75:25), gave the 
amines 6d and 7d (65 mg, 69%) as a separable mixture (ratio 2:1): 
Amine 6d (44 mg) as an oil; Rf 0.2 [petrolÐEtOAc (90:10)]; FT-IR νmax 
(film)/cm
-1
 3330, 3060, 3020, 1500; 
1
H NMR (400 MHz, CDCl3) δ = 7.50Ð
7.47 (2H, m, 2 × ArH), 7.39Ð7.16 (12H, m, 12 × ArH), 4.44Ð4.37 (2H, m, 
2 × CH), 3.26Ð3.20 (1H, m, CH), 3.16Ð3.10 (1H, m, CH), 3.06Ð3.00 (2H, 
m, 2 × CH), 2.03 (1H, br s, NH); 
13
C NMR (100 MHz, CDCl3) δ = 144.1, 
139.1, 137.9, 134.8, 129.3, 129.1, 128.8, 128.6, 127.5, 127.3, 126.9, 
126.5, 126.4, 125.8, 58.4, 51.8, 42.9, 38.2; HRMS (ES) Found: MH
+
, 
300.1719. C22H21N requires MH
+
 300.1746; LRMS m/z (ES) 300 (100%, 
MH
+
). Amine 6d is known but no data were reported.
[18] 
Amine 7d (21 mg) as an oil; Rf 0.2 [petrolÐEtOAc (80:20)]; FT-IR νmax 
(film)/cm
-1
 3330, 3060, 3020, 1500; 
1
H NMR (400 MHz, CDCl3) δ = 7.37Ð
7.35 (2H, m, 2 × ArH), 7.28Ð7.06 (9H, m, 9 × ArH), 6.88Ð6.87 (3H, m, 3 × 
ArH), 4.00 (1H, d, J 16 Hz, CH), 3.79 (1H, d, J 16 Hz, CH), 3.25 (1H, d, J 
16 Hz, CH), 3.11Ð3.01 (3H, m, 3 × CH), 1.79 (1H, br s, NH); 
13
C NMR 
(100 MHz, CDCl3) δ = 143.2, 136.7, 135.1, 134.0, 130.6, 129.1, 128.0, 
127.7, 127.2, 126.5, 126.4, 125.9, 125.7, 125.6, 58.2, 50.8, 44.4, 36.8; 
HRMS (ES) Found: MH
+
, 300.1717. C22H21N requires MH
+
 300.1746; 
LRMS m/z (ES) 300 (100%, MH
+
). 
(1S,3R)-1-(4-Methylbenzyl)-3-phenyl-1,2,3,4-tetrahydroisoquinoline 
6e: 
Trifluoroacetic acid (0.13 mL, 1.8 mmol) was added to a mixture (ratio 3:1) 
of carbamates 4e and 5e (370 mg, 0.9 mmol) in CH2Cl2 (10 mL) at room 
temperature. After 4 h, the solvent was evaporated and aqueous NaOH 
(5 mL, 1 M) was added. After 1 h, the mixture was extracted with CH2Cl2 
(2 × 50 mL). The combined organic extracts were dried (MgSO4) and the 
solvent was evaporated. Purification by flash column chromatography on 
silica, eluting with petrolÐEtOAc (60:40), gave the amine 6e (160 mg, 
57%) as plates; m.p 71Ð73 ¡C; Rf 0.4 [petrolÐEtOAc (80:20)]; FT-IR νmax 
(film)/cm
-1
 3315, 3020, 2920, 1515, 1490; 
1
H NMR (400 MHz, CDCl3) δ = 
7.48Ð7.46 (2H, m, 2 × ArH), 7.40Ð7.37 (2H, m, 2 × ArH), 7.34Ð7.22 (4H, 
m, 4 × ArH), 7.18Ð7.13 (5H, m, 5 × ArH), 4.40Ð4.37 (2H, m, 2 × CH), 
3.21Ð3.15 (1H, m, CH), 3.11Ð2.98 (3H, m, 3 × CH), 2.35 (3H, s, CH3), 
1.94 (1H, br s, NH);  
13
C NMR (100 MHz, CDCl3) δ = 144.1, 138.0, 136.1, 
135.9, 134.7, 129.5, 129.2, 129.1, 128.6, 127.5, 127.3, 126.9, 126.4, 
125.8, 58.4, 51.8, 42.5, 38.2, 21.1; HRMS (ES) Found: MH
+
, 314.1914. 
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C23H23N requires MH
+
 314.1903; LRMS m/z (ES) 314 (100%, MH
+
); 
CCDC 1889262. 
(5S,10bR)-5-Phenyl-1H,2H,3H,5H,6H,10bH-pyrrolo[2,1-a]isoquinoline 
8 and 10a-Phenyl-1H,2H,3H,5H,10H-pyrrolo[1,2-b]isoquinoline 9: 
nBuLi (0.24 mL, 0.57 mmol, 2.4 M in hexane) was added to the 
carbamate 1 (150 mg, 0.48 mmol) in dry THF (3 mL) at Ð50 ¼C under 
nitrogen. After 4 minutes, Br(CH2)3Br (0.14 mL, 1.44 mmol) was added. 
The mixture was allowed to warm slowly to room temperature and the 
solvent was evaporated. To this mixture (220 mg) was added 
trifluoroacetic acid (2.6 mL, 0.2 mmol) in CH2Cl2 (5 mL) and the mixture 
was stirred at room temperature. After 4 h, the solvent was evaporated 
and aqueous NaOH (20 mL, 1 M) was added. After 1 h, the mixture was 
extracted with CH2Cl2 (2 × 30 mL). The combined organic extracts were 
dried (MgSO4) and the solvent was evaporated. Purification by column 
chromatography on silica, eluting with petrolÐEtOAc (95:5), gave the 
amines 8 and 9 (86 mg, 75%) as separable regioisomers (ratio 2:1): 
Amine 8 (56 mg) as a gum; RÄ 0.22  [petrolÐEtOAc (80:20)]; FT-IR νmax 
(film)/cm
-1
 3000, 2990, 2950, 1450;
 
 
1
H NMR (400 MHz, CDCl3) δ = 7.41Ð
7.34 (4H, m, 4 × ArH), 7.32Ð7.28 (1H, m, ArH), 7.25Ð7.13 (4H, m, 4 × 
ArH), 4.23 (1H, t, J  8 Hz , CH), 3.88 (1H, dd, J 9.5, 4 Hz, CH), 3.15Ð3.08 
(1H, m, CH), 3.02Ð2.97 (1H, m, CH), 2.88Ð2.83 (1H, m, CH), 2.80Ð2.74 
(1H, m, CH), 2.42Ð2.34 (1H, m, CH), 1.92Ð1.80 (2H, m,  2 × CH), 1.61Ð
1.50 (1H, m, CH); 
13
C NMR (100 MHz, CDCl3) δ = 143.1, 138.6, 134.8, 
128.4, 127.8, 127.7, 127.2, 126.2, 126.1, 126.0, 60.8, 60.5, 52.4, 38.6, 
32.0, 23.1; HRMS (ES) Found: MH
+
, 250.1591. C18H19N requires MH
+
 
250.1590; LRMS m/z (ES) 250 (100%, MH
+
). 
Amine 9 (30 mg) as a gum; RÄ 0.25 [petrolÐEtOAc (80:20)]; FT-IR νmax 
(film)/cm
Ð 1
 2950, 2920, 1600, 1450;
 
 
1
H NMR (400 MHz, CDCl3) δ = 
7.58Ð7.56 (1H, m, 1 × ArH), 7.32Ð7.10 (8H, m, 8 × ArH), 3.90 (1H, d, J 
16 Hz, CH), 3.79 (1H, d, J 16 Hz, CH), 3.24 (1H, t, J 7.5 Hz, CH), 3.14 
(1H, d, J 16 Hz, CH), 2.95 (1H, d, J 16 Hz, CH), 2.70 (1H, q, J 7.5 Hz, 
CH), 2.15Ð2.09 (1H, m, CH), 1.85Ð1.69 (3H, m, 3 × CH);
 13
C NMR (100 
MHz, CDCl3) δ = 148.4, 136.5, 135.4, 128.4, 127.9, 126.5, 126.4, 126.0, 
125.8, 125.4, 65.4, 53.0, 50.0, 41.6, 36.7, 22.1; HRMS (ES) Found: MH
+
, 
250.1591. C18H19N requires MH
+
 250.1589; LRMS m/z (ES) 250 (100%, 
MH
+
). Data in accordance with the literature.
[19]
  
(6S,11bR)-6-Phenyl-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-
a]isoquinoline 10  and 11a-Phenyl-1H,2H,3H,4H,6H,11H-pyrido[1,2-
b]isoquinoline 11: 
nBuLi (0.24 mL, 0.57 mmol, 2.4 M in hexane) was added to the 
carbamate 1 (150 mg, 0.48 mmol) in dry THF (3 mL) at Ð50 ¼C under 
nitrogen. After 4 minutes, Br(CH2)4Br (0.17 mL, 1.44 mmol) was added. 
The mixture was allowed to warm slowly to room temperature and the 
solvent was evaporated. To this mixture (240 mg) was added 
trifluoroacetic acid (2.7 mL, 0.2 mmol) in CH2Cl2 (5 mL) and the mixture 
was stirred at room temperature. After 4 h, the solvent was evaporated 
and aqueous NaOH (5 mL, 1 M) was added. After 1 h, the mixture was 
extracted with CH2Cl2 (2 × 30 mL). The combined organic extracts were 
dried (MgSO4) and the solvent was evaporated. Purification by column 
chromatography on silica, eluting with petrolÐEtOAc (95:5), gave the 
amines 10 and 11 (110 mg, 87%) as separable regioisomers (ratio 2:1): 
Amine 10 (80 mg) as a gum; RÄ 0.22  [petrolÐEtOAc (80:20)]; FT-IR νmax 
(film)/cm
-1
 3005, 2970, 1480;
 
 
1
H NMR (400 MHz, CDCl3) δ = 7.33Ð7.32 
(3H, m, 3 × ArH), 7.21Ð7.15 (6H, m, 6 × ArH), 4.24 (1H, t, J 6 Hz, CH), 
3.60Ð3.44 (2H, m, 2 × CH), 3.10Ð2.97 (2H, m, 2 × CH), 2.45Ð2.39 (1H, m, 
CH), 2.15Ð2.12 (1H, m, CH), 1.89Ð1.86 (1H, m, CH), 1.73Ð1.60 (2H, m, 2 
× CH), 1.50Ð1.43 (2H, m, 2 × CH); 
13
C NMR (100 MHz, CDCl3) δ = 144.9, 
139.5, 133.6, 128.7, 128.6, 128.1, 127.4, 126.2, 125.7, 125.5, 60.3, 57.7, 
52.3, 36.0, 31.2, 25.0, 23.3; HRMS (ES) Found: MH
+
, 264.1748. C19H21N 
requires MH
+
 264.1747; LRMS m/z (ES) 264 (100%, MH
+
). 
Amine 11 (30 mg) as a gum; RÄ 0.54 [petrolÐEtOAc (80:20)]; FT-IR νmax 
(film)/cm
Ð 1
 2960, 2940, 1450;
 
 
1
H NMR (400 MHz, CDCl3) δ = 7.56Ð7.55 
(2H, m, 2 × ArH), 7.28Ð7.13 (5H, m, 5 × ArH), 7.10Ð7.05 (1H, m, ArH), 
6.87Ð6.85 (1H, m, ArH), 3.83 (1H, d, J 17 Hz, CH), 3.58 (1H, d, J 17 Hz, 
CH), 3.41 (1H, d, J 17 Hz, CH), 3.02 (1H, d, J 17 Hz, CH), 2.88Ð2.83 (2H, 
m, 2 × CH), 1.88Ð1.78 (3H, m, 3 × CH), 1.72Ð1.61 (3H, m, 3 × CH); 
13
C 
NMR (100 MHz, CDCl3) δ = 147.0, 134.2, 133.6, 128.7, 128.1, 126.7, 
126.5, 126.4, 125.9, 125.7, 58.9, 53.4, 49.3, 40.2, 26.2, 25.9, 21.1; 
HRMS (ES) Found: MH
+
, 264.1748. C19H21N requires MH
+
 264.1745; 
LRMS m/z (ES) 264 (100%, MH
+
).  
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